- AREAS OF RESEARCH
- GET CONNECTED
The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of moderate or severe migraine in children and adolescents (≥ 6 to \< 18 years of age).
Closest Location
Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.
Condition
Acute Treatment of Migraine
Sex
Male or Female
Age
6 - 17 years